Stories Related to Fda Oks New Therapy For Some Hemophilia Patients

TRENTON, N.J. (AP) — U.S. regulators have approved the first new treatment in nearly two decades to prevent internal bleeding in certain patients with hemophilia.

Sections:  news   u.s.   
Topics:  Texas   McLennan County   Waco   
RELATED ARTICLES
BING NEWS:
  • FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia
    FDA approves Pfizer's Beqvez for adults with hemophilia B, offering a one-time treatment to produce FIX. Experience reduced bleeding frequency. Explore Pfizer's warranty program.
    04/26/2024 - 7:30 am | View Link
  • US Approves Gene Therapy Treatment For Hemophilia
    Pharmaceutical giant Pfizer has received US approval for a gene therapy against a form of hemophilia, a rare and inherited blood clotting disorder, the company said Friday.
    04/26/2024 - 7:04 am | View Link
  • Pfizer gets FDA approval for hemophilia B gene therapy Beqvez
    Pfizer (PFE) said it has received FDA approval for its one-time gene therapy Beqvez for the treatment of certain adults with hemophilia B. Read more here.
    04/26/2024 - 5:38 am | View Link
  • FDA Approves Second Gene Therapy for Hemophilia B
    Pfizer reported a list price of $3.5 million for its new gene therapy, Beqvez, for adults with this rare bleeding disorder.
    04/26/2024 - 3:38 am | View Link
  • FDA approves Beqvez gene therapy for adults with hemophilia B
    Beqvez is indicated for those on preventive treatment with a factor IX replacement therapy or have had life-threatening bleeding episodes.
    04/26/2024 - 2:39 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More U.s. News